Tardive dyskinesia and covert dyskinesia with aripiprazole: A case series

Current Drug Safety

Volumn 11, Issue 1, 2016, Pages 102-103

  Patra, Suravi ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Aripiprazole; Covert dyskinesia; Tardive dyskinesia

Indexed keywords

ALPHA TOCOPHEROL; ARIPIPRAZOLE; DOSULEPIN; ESCITALOPRAM; FLUOXETINE; RISPERIDONE; TETRABENAZINE; TRIHEXYPHENIDYL; NEUROLEPTIC AGENT;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; AKATHISIA; ARTICLE; CASE REPORT; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSKINESIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; JAW MOVEMENT; MALE; MASTICATION; MIDDLE AGED; PARANOIA; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; TARDIVE DYSKINESIA; YOUNG ADULT; DYSKINESIA, DRUG-INDUCED;

ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; TARDIVE DYSKINESIA; YOUNG ADULT;

EID: 84959861336     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574886310666150921104343     Document Type: Article

References (10)

1. Rosenheck RA. Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics. Br J Psychiatry 2007; 191: 238-45.
2. Shapiro DA, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003; 28(8): 1400-11.
3. Rajarethinam R, Dziuba J, Manji S, Pizzuti A, Lachover L, Keshavan M. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. World J Biol Psychiatry 2009; 10: 416-9.
4. Peña MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord 2011; 26(1): 147-52.
5. Goyal R, Devi SH. A case of aripiprazole induced tardive dyskinesia in a neuroleptic-naïve patient with two years of follow up. Clin Psychopharmacol Neurosci 2014; 12(1): 69-71.
6. Schwartz T, Raza S. Aripiprazole (abilify) and tardive dyskinesia. PT 2008; 33(1): 32-4.
7. Guy W. ECDEU assessment manual for psychopharmacology revised DHEW pub (ADM). National Institute for Mental Health 1976. https://archive.org/stream/ecdeuassessmentm1933guyw/ecdeuassessmentm1933guyw_djvu.txt.
8. Leo RJ. Movement disorders associated with the serotonin selective reuptake Inhibitors. J Clin Psychiatry 1996; 57(10): 449-54.
9. Bhidayasiri R, Fahn S, Weiner WJ, Gronseth GS, Sullivan KL, Zesiewicz TA. Evidence-based guideline: Treatment of tardive syndromes: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013; 30; 81(5): 463-9.
10. Moseley CN, Simpson-Khanna HA, Catalano G, Catalano MC. Covert dyskinesia associated with aripiprazole: a case report and review of the literature. Clin Neuropharmacol 2013; 36(4): 128-30.